Virtual reality-paired opioid analgesia as contextual prophylaxis against iatrogenic opioid addiction: a hypothesis

• Medical opioid use carries a small but significant risk of persistent use post-discharge. • Pairing opioid administration with immersive virtual reality (VR) may confine opioid-related learning to artificial contexts, reducing real-world cravings and use. • If effective, VR-paired opioid administration would introduce context as a modifiable risk factor, offering a novel pathway for preventing iatrogenic opioid use disorder. Opioid analgesics are indispensable for treating moderate-severe inpatient pain, yet even supervised use can precipitate long-term opioid use or opioid use disorder (OUD) in a small but consequential fraction of patients. Current prevention approaches emphasize screening, dosing, and duration, but rarely treat context as a modifiable risk factor. Pavlovian models show that drug effects become tightly linked to environmental cues, influencing tolerance, craving, and overdose risk; conversely, major contextual changes can disrupt addictive patterns. Virtual reality (VR) offers immersive, controllable contexts that already demonstrate analgesic and anxiolytic benefits, and can reliably engage drug-related cue learning. The present paper hypothesizes that systematically pairing inpatient opioid administration with distinctive, varied VR contexts could ‘capture’ opioid-associated learning within artificial contexts and reduce generalization of conditioned responses to post-discharge environments. Combined with VR’s intrinsic analgesic effects, which may reduce total opioid exposure, this strategy could act as a multi-level behavioral prophylaxis against persistent opioid use post-discharge. The conditioning rationale, potential risks, implementation principles, and a three-arm trial to test VR-based contextual prophylaxis during medical opioid therapy are discussed.